Biomarin Pharmaceutical Inc. · NASDAQ:BMRN

BlackRock, Inc. reported a 10.80% stake in Biomarin Pharmaceutical Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 29, 2025

BlackRock, Inc. reported a 10.80% stake in Biomarin Pharmaceutical Inc., 20,620,179 shares, as a passive investor on Mar 31, 2025. Filed Apr 29, 2025 (Schedule 13G/A).

Stake
10.80%
Shares
20,620,179
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.10.80%20,620,179

Source

View original at SEC

Related